Amarin Corp Plc (AMRN)

[jessellivermore]

HDG..

"Interim @50% (modified R-IT's SPA) was raised by me as a possible element of the settlement. That's it."

Thanks, but no thanks. R-I belongs to the company, not to the FDA. The company can do anything wants including halting the trial today, or next week, and it does not need FDA's permission. Obviously halting the trial at this point is not a good idea. In fact as an operating principle anything Amarin does to change the trial design, at this point, carries the potential risk that it will weaken the results. Amarin needs be more worried about the opinion of the medical community in this case than the FDA. So the best policy is to stick to the pre-trial protocol which is designed to produce meaningful data, and not open the presents before Christmas.

":>) JL